SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Park Kyong Su)
 

Sökning: WFRF:(Park Kyong Su) > Targeting Myd88 usi...

Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation

Park, Kyong-Su (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Bergqvist, Markus, 1995 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Lässer, Cecilia, 1981 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
visa fler...
Lötvall, Jan, 1956 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
visa färre...
 (creator_code:org_t)
2022-10-15
2022
Engelska.
Ingår i: Journal of Nanobiotechnology. - : Springer Science and Business Media LLC. - 1477-3155. ; 20:1
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Mesenchymal stem cells (MSC) secrete extracellular vesicles (EV) with a regenerative profile, and an increasing number of studies have focused on the utilization of MSC-EV for therapeutic drug delivery. However, EV are usually produced by cells in low quantities and are packed with numerous cytoplasmic components, which may be unfavorable for further drug loading. In this study, we developed a simple process for generating membrane vesicles directly from the cells, which we refer to as synthetic eukaryotic vesicles (SyEV). We hypothesized that MSC-derived SyEV can be efficiently loaded with an anti-inflammatory drug and the loaded vesicles can strongly suppress the systemic inflammation induced by bacterial outer membrane vesicles (OMV). SyEV were generated from MSC membranes through serial extrusion of the cells, ionic stress, and subsequent vesiculation of the membrane sheets, leading to high yield and purity of the SyEV with few cytosolic components remaining. When these SyEV were given to macrophages or mice exposed to OMV, the release of pro-inflammatory cytokines was similarly attenuated comparable to treatment with natural EV. We then loaded the SyEV with large numbers of peptides targeting Myd88 and observed enhanced therapeutic potential of the loaded vesicles in OMV-induced macrophages. Further, in vivo experiments showed that the peptide-encapsulated MSC-SyEV suppressed cytokine production synergistically. Taken together, these findings suggest that SyEV-based therapeutics is a highly interesting platform for delivering an advanced therapeutic drug for the treatment of systemic inflammation without severe side effects.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine (hsv//eng)

Nyckelord

Engineered extracellular vesicles
Synthetic eukaryotic vesicles
Mesenchymal stem cells
Systemic inflammation
Anti-inflammation
Drug
delivery
Therapy
extracellular vesicles
exosomes
delivery
sepsis
injury
Biotechnology & Applied Microbiology
Science & Technology - Other
Topics

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Park, Kyong-Su
Bergqvist, Marku ...
Lässer, Cecilia, ...
Lötvall, Jan, 19 ...
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Medicinska och f ...
Artiklar i publikationen
Journal of Nanob ...
Av lärosätet
Göteborgs universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy